Concepedia
Statistics
Publications
5
Citations
342
H-Index
Active since
2004
Affiliations
University Hospital Münster(Current)
University of Münster
J Tio is an author at University Hospital Münster specializing in medicine, molecular oncology, and breast oncology.
Publications per year
2004–2021
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)
Gϋnter von Minckwitz, Gϋnter von Minckwitz, Sibylle Loibl et al. · Annals of Oncology · 2014 · 140 citations
Medicine, Oncology, Pharmacology +15
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
Philipp Backhaus, F. Gierse, Matthias C. Burg et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 101 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
P Wülfing, Christian Kersting, Horst Buerger et al. · British Journal of Cancer · 2005 · 43 citations · Full text
Medicine, Oncology, Pathology +17
Expression of Endothelin-A-Receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer
P Wülfing, J Tio, Christian Kersting et al. · British Journal of Cancer · 2004 · 29 citations · Full text
Medicine, Cancer Biology, Oncology +13
Abstract S5-03: Final analysis of WSG-ADAPT HER2+/HR+ phase II trial: Efficacy, safety, and predictive markers for 12-weeks of neoadjuvant TDM1 with or without endocrine therapy versus trastuzumab+endocrine therapy in HER2-positive hormone-receptor-positive early breast cancer
Nadia Harbeck, Oleg Gluz, Matthias Christgen et al. · Cancer Research · 2016 · 29 citations
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 5